Stereotactic Radiosurgery: An Update: Interim Report
0
0
As an Amazon Associate and affiliate partner, Menrva Books earns from qualifying purchases. Learn more
Author Description
The present report is consistent with findings from assessments by other agencies that the quality of the available evidence on SRS effectiveness in comparison with other types of treatment is limited. There is still no evidence that any one form of SRS is superior over another. There is some indication, from small studies, of similar outcomes from the Gamma Knife (GK) and focused linear acceleration (LUMAC) versions of SRS. There is increasing use of fractionated stereotactic radiotherapy (FSRT) as an alternative or supplement to SRS. There is some indication, from small series, that FSRT may have advantages over SRS in some situations in terms of indcience of complications. A version of SRS, using robotic technology (the Cyberknife), that enables treatment any part of the body is now commercially available and preliminary clinical results have been published. The GK approach is more expensive than that using standard LINAC approaches or FSRT. Costs of using recent developments in LINAC technology are not yet clear. Many journal articles, as well as HTA reports, confirm advice given in earlier AHFMR assessments that excellent quality assurance and placement of SRS in specialized centres are essential.
Menrva's Summary
THE THESIS
This report assesses the current evidence regarding the effectiveness and cost of stereotactic radiosurgery (SRS) and its alternatives. The Alberta Heritage Foundation for Medical Research's Health Technology Assessment Unit, in collaboration with David Hailey, presents an interim report that synthesizes findings from various agencies. It highlights the limited quality of evidence comparing SRS to other treatments and notes that no single SRS method has proven superior. The report also examines the increasing use and potential advantages of fractionated stereotactic radiotherapy (FSRT) and introduces newer technologies like the Cyberknife.
THE SCOPE MAP
- Assessment of the comparative effectiveness of Stereotactic Radiosurgery (SRS) versus other treatment modalities.
- Analysis of the evidence for superiority among different forms of SRS, including Gamma Knife (GK) and focused linear acceleration (LUMAC).
- Evaluation of Fractionated Stereotactic Radiotherapy (FSRT) as an alternative or supplement to SRS, including its complication rates.
- Introduction to robotic SRS technology, such as the Cyberknife, and its preliminary clinical results.
- Comparative cost analysis of different SRS approaches, including GK, standard LINAC, and FSRT.
- Emphasis on the critical importance of excellent quality assurance and specialized center placement for SRS procedures.
THE AUTHORITY PERSPECTIVE
This report, consistent with assessments by other agencies, indicates that the evidence base for the effectiveness of stereotactic radiosurgery (SRS) compared to alternative treatments is limited. While no single SRS method has demonstrated superiority, small studies suggest similar outcomes between Gamma Knife and focused linear acceleration versions. The report notes the growing adoption of fractionated stereotactic radiotherapy (FSRT) as a viable alternative or adjunct, potentially offering advantages in complication rates in certain situations. The introduction of robotic systems like the Cyberknife is also discussed, alongside cost considerations for various technologies.
Page Count:
102
Publication Date:
2002-01-01
Publisher:
Alberta Heritage Foundation for Medical Research
ISBN-10:
1896956564
ISBN-13:
9781896956565
Science & Technology
Non-Fiction
Radiology
Community Tags
Similar Books
